These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29226461)

  • 1. Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review.
    Zou Y; Zhong Y; Wu J; Xiao H; Zhang X; Liao X; Li J; Mao X; Liu Y; Zhang F
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-ATB: An indispensable cancer-related long noncoding RNA.
    Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding SNHG1 in cancer.
    Thin KZ; Tu JC; Raveendran S
    Clin Chim Acta; 2019 Jul; 494():38-47. PubMed ID: 30849309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
    Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
    BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer.
    Rivandi M; Pasdar A; Hamzezadeh L; Tajbakhsh A; Seifi S; Moetamani-Ahmadi M; Ferns GA; Avan A
    J Cell Physiol; 2019 Feb; 234(2):1230-1236. PubMed ID: 30191971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.
    Liu J; Ben Q; Lu E; He X; Yang X; Ma J; Zhang W; Wang Z; Liu T; Zhang J; Wang H
    Cell Death Dis; 2018 Feb; 9(2):168. PubMed ID: 29416011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
    Xin Y; Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.
    Zhang F; Li J; Xiao H; Zou Y; Liu Y; Huang W
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29057544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer.
    Ma P; Xu T; Huang M; Shu Y
    Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs in retinoblastoma.
    Yang M; Wei W
    Pathol Res Pract; 2019 Aug; 215(8):152435. PubMed ID: 31202519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma.
    Xu Y; Jiang X; Cui Y
    Onco Targets Ther; 2017; 10():2873-2883. PubMed ID: 28652769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer.
    Yang J; Zhao S; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4706-4712. PubMed ID: 31210296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.